This inventor holds 6 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: University of California. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovations of Philip Scumpia
Introduction
Philip Scumpia is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of hydrogel materials, particularly in modulating immune responses. With a total of 6 patents to his name, his work continues to impact both research and practical applications in medicine.
Latest Patents
Among his latest patents are two notable innovations. The first is titled "Microporous Annealed Particle Gels and Methods of Use." This patent describes a hydrogel material designed to modulate an immune response in humans and other mammals. It includes a collection of microgel particles that, when exposed to an annealing agent, link together to form a covalently-stabilized scaffold. This scaffold has interstitial spaces that can accommodate antigens and adjuvants, enhancing its effectiveness.
The second patent, "Microporous Annealed Particle Gel System," also focuses on hydrogel materials. It outlines a similar collection of microgel particles that form a scaffold with pores devoid of hydrogel. This innovation aims to improve the delivery and efficacy of therapeutic agents in medical applications.
Career Highlights
Philip Scumpia is affiliated with the University of California, where he conducts his research and development. His work has garnered attention for its potential applications in immunology and therapeutic interventions. His innovative approach to hydrogel technology has positioned him as a leading figure in this specialized field.
Collaborations
Some of his notable coworkers include Donald R. Griffin and Tatiana Segura. Their collaborative efforts have contributed to the advancement of hydrogel research and its applications in medicine.
Conclusion
Philip Scumpia's contributions to hydrogel technology and immune modulation are noteworthy. His patents reflect a commitment to innovation and the potential to improve medical treatments. His work continues to inspire advancements in the field of biomedical engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile